Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Study of Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Hematological Malignancies
United States, Belgium, Canada, China, France +6 more
Sponsor: Biogen
Microvascular Inflammation
United States, Argentina, Australia, Austria, Brazil +6 more
Sponsor: AbbVie
Juvenile Psoriatic Arthritis
United States, Australia, Canada, France, Germany +4 more
- A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)Active Not Recruiting
Sponsor: Agios Pharmaceuticals, Inc.
Transfusion-dependent Alpha-Thalassemia · Transfusion-dependent Beta-Thalassemia
United States, Brazil, Bulgaria, Canada, Denmark +14 more
- Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With DocetaxelRecruiting
Sponsor: University of Erlangen-Nürnberg Medical School
Squamous Cell Carcinoma of Oropharynx · Squamous Cell Carcinoma of the Hypopharynx · Larynx Squamous Cell Carcinoma · Oral Cavity Squamous Cell Carcinoma
Germany
Sponsor: Hoffmann-La Roche
Choroidal Neovascularization Secondary to Pathologic Myopia
Australia, China, France, Germany, Hong Kong +6 more
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Argentina, Australia, Belgium, Brazil +23 more
- A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Crohn Disease · Colitis, Ulcerative · Arthritis, Psoriatic
United States, Argentina, Belgium, France, Germany +8 more
- An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative ColitisActive Not Recruiting
Sponsor: Janssen Biotech, Inc.
Ulcerative Colitis
United States, Austria, Canada, Czechia, France +4 more
Sponsor: AstraZeneca
Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +30 more
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Colitis, Ulcerative
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Janssen Research & Development, LLC
Non-Muscle Invasive Bladder Neoplasms
United States, Argentina, Belgium, Brazil, China +10 more
- An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic CholangiocarcinomaActive Not Recruiting
Sponsor: Servier Affaires Médicales
Cholangiocarcinoma
Armenia, Australia, Austria, Belgium, Canada +11 more
- A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical RoutineActive Not Recruiting
Sponsor: Sanofi
Prurigo Nodularis
Germany
Sponsor: iOMEDICO AG
Cholangiocarcinoma
Germany
Sponsor: Janssen Research & Development, LLC
Advanced or Metastatic Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Brazil, China, France +6 more
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Arthritis, Psoriatic
United States, Argentina, Australia, Bulgaria, Canada +21 more
Sponsor: University of Erlangen-Nürnberg Medical School
Cancer of Head and Neck
Germany
Sponsor: Janssen Research & Development, LLC
Lupus Erythematosus, Systemic
United States, Argentina, Australia, Brazil, Bulgaria +24 more
Sponsor: Janssen Research & Development, LLC
Neoplasms
United States, Canada, China, France, Germany +5 more
Sponsor: Philogen S.p.A.
Locally Advanced Basal Cell Carcinoma
United States, Germany, Greece, Italy, Spain
Sponsor: Janssen Research & Development, LLC
Hemolytic Disease of the Fetus and Newborn
United States, Argentina, Australia, Austria, Belgium +12 more
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationActive Not Recruiting
Sponsor: Novo Nordisk A/S
Heart Failure · Systemic Inflammation
United States, Argentina, Australia, Bulgaria, Canada +11 more
Sponsor: University of Oxford
Cardiovascular Diseases · Cardiovascular Risk Factors
United States, Australia, Belgium, Cyprus, Denmark +9 more